Academic Pediatrics
Volume 9, Issue 5 , Pages 344-347 , September 2009

Cocooning Infants: Tdap Immunization for New Parents in the Pediatric Office

Received 4 December 2008 ,Revised 13 May 2009 ,Accepted 19 May 2009.

References 

  1. Centers for Disease Control and Prevention. Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP) and Recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC) for use of Tdap among health-care personnel. Morbidity and Mortality Weekly Report Recomm Rep. 2006;55(RR-17):1–37
  2. Centers for Disease Control and Prevention. Summary of notifiable diseases–United States 2006. Morbidity and Mortality Weekly Report. 2008;55:1–100
  3. Tanaka M, Vitek CR, Pascual FB, et al. Trends in pertussis among infants in the United States, 1980–1999. JAMA. 2003;290:2968–2975
  4. Vitek CR, Pascual FB, Baughman AL, Murphy TV. Increase in deaths from pertussis among young infants in the United States in the 1990s. Pediatr Infect Dis J. 2003;22:628–634
  5. Bisgard KM, Pascual FB, Ehresmann KR, et al. Infant pertussis: who was the source?. Pediatr Infect Dis J. 2004;23:985–989
  6. Wendelboe AM, Njamkepo E, Bourillon A, et al. Transmission of Bordetella pertussis to young infants. Pediatr Infect Dis J. 2007;26:293–299
  7. Kowalzik F, Barbosa AP, Fernandes VR, et al. Prospective multinational study of pertussis infection in hospitalized infants and their household contacts. Pediatr Infect Dis J. 2007;26:238–242
  8. Centers for Disease Control and Prevention. Prevention of pertussis, tetanus, and diphtheria among pregnant and postpartum women and their infants: recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbidity and Mortality Weekly Report. 2008;57:(RR-04)
  9. Dylag AM, Shah SI. Administration of tetanus, diphtheria, and acellular pertussis vaccine to parents of high-risk infants in the neonatal intensive care unit. Pediatrics. 2008;122:e550–e555

 Dr Walter is a speaker for Sanofi Pasteur and has served as a principal investigator for other clinical investigations sponsored by Sanofi Pasteur. The views in this article are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention, U.S. Department of Health and Human Services.

PII: S1876-2859(09)00145-4

doi: 10.1016/j.acap.2009.05.027

Academic Pediatrics
Volume 9, Issue 5 , Pages 344-347 , September 2009

Article Tools